Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Denali Therapeutics Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $100 Billion
- Q4 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 1,001 shares of DNLI stock, worth $18,618. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,001
Previous 1,001
-0.0%
Holding current value
$18,618
Previous $29,000
31.03%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding DNLI
# of Institutions
240Shares Held
121MCall Options Held
80KPut Options Held
36.8K-
Black Rock Inc. New York, NY13.2MShares$245 Million0.01% of portfolio
-
Baillie Gifford & CO12.3MShares$229 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$224 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA9.85MShares$183 Million0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.48MShares$102 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.5B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...